Analyst Rating: Will Amgen, Inc. (AMGN) Stock Outperform the Market?

InvestorsObserver is giving Amgen, Inc. (AMGN) an Analyst Rating Rank of 19, meaning AMGN is ranked higher by analysts than 19% of stocks. The average price target for AMGN is $242.866 and analyst’s rate the stock as a Buy.

Wall Street analysts are rating AMGN a Buy today. Find out what this means to you and get the rest of the rankings on AMGN!

See Full AMGN Report

Why are Analyst Ratings Important?

Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported. InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.

What's Happening With Amgen, Inc. Stock Today?

Amgen, Inc. (AMGN) stock is lower by -1.1% while the S&P 500 has gained 0.39% as of 2:00 PM on Monday, Nov 22. AMGN is lower by -$2.26 from the previous closing price of $206.08 on volume of 1,657,792 shares. Over the past year the S&P 500 is higher by 31.83% while AMGN is lower by -8.28%. AMGN earned $9.71 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 21.01. Click Here to get the full Stock Report for Amgen, Inc. stock.